210 related articles for article (PubMed ID: 31593523)
1. A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.
Brems JH; McCoy MS
AJOB Empir Bioeth; 2019; 10(4):215-221. PubMed ID: 31593523
[No Abstract] [Full Text] [Related]
2. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
Rose SL; Highland J; Karafa MT; Joffe S
JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
Li DG; Singer S; Mostaghimi A
JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Potential Conflicts of Interest among Otolaryngologic Patient Advocacy Organizations in 2016.
Kondamuri NS; Rathi VK; Naunheim MR; Sethi RV; Miller AL; Varvares MA
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):967-969. PubMed ID: 31479391
[TBL] [Abstract][Full Text] [Related]
5. Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.
Rose SL
J Law Med Ethics; 2013; 41(3):680-7. PubMed ID: 24088159
[TBL] [Abstract][Full Text] [Related]
6. When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.
Ehrlich O; Wingate L; Heller C; de Melo-Martin I
BMC Med Ethics; 2019 Dec; 20(1):96. PubMed ID: 31847854
[TBL] [Abstract][Full Text] [Related]
7. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey.
Ball DE; Tisocki K; Herxheimer A
BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025
[TBL] [Abstract][Full Text] [Related]
8. Policies on faculty conflicts of interest at US universities.
Cho MK; Shohara R; Schissel A; Rennie D
JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591
[TBL] [Abstract][Full Text] [Related]
9. A national survey of policies on disclosure of conflicts of interest in biomedical research.
McCrary SV; Anderson CB; Jakovljevic J; Khan T; McCullough LB; Wray NP; Brody BA
N Engl J Med; 2000 Nov; 343(22):1621-6. PubMed ID: 11096171
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context.
Kang SY; Bai G; Karas L; Anderson GF
Am J Public Health; 2019 Apr; 109(4):559-561. PubMed ID: 30789768
[TBL] [Abstract][Full Text] [Related]
11. Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.
Rothman SM; Raveis VH; Friedman A; Rothman DJ
Am J Public Health; 2011 Apr; 101(4):602-9. PubMed ID: 21233424
[TBL] [Abstract][Full Text] [Related]
12. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.
Weinfurt KP; Dinan MA; Allsbrook JS; Friedman JY; Hall MA; Schulman KA; Sugarman J
Acad Med; 2006 Feb; 81(2):113-8. PubMed ID: 16436571
[TBL] [Abstract][Full Text] [Related]
13. Beyond Disclosure: Developing Law and Policy to Tackle Corporate Influence.
Marks JH
Am J Law Med; 2020 May; 46(2-3):275-296. PubMed ID: 32659196
[TBL] [Abstract][Full Text] [Related]
14. Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.
Cosgrove L; Krimsky S; Wheeler EE; Peters SM; Brodt M; Shaughnessy AF
Account Res; 2017; 24(2):99-115. PubMed ID: 27901595
[TBL] [Abstract][Full Text] [Related]
15. Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice.
Shimazawa R; Ikeda M
Psychiatry Clin Neurosci; 2014 Jul; 68(7):489-97. PubMed ID: 24802771
[TBL] [Abstract][Full Text] [Related]
16. A turning point for conflicts of interest: the controversy over the National Academy of Sciences' first conflicts of interest disclosure policy.
Parascandola M
J Clin Oncol; 2007 Aug; 25(24):3774-9. PubMed ID: 17704427
[TBL] [Abstract][Full Text] [Related]
17. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
18. Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.
Grundy Q; Habibi R; Shnier A; Mayes C; Lipworth W
Health Policy; 2018 May; 122(5):509-518. PubMed ID: 29605526
[TBL] [Abstract][Full Text] [Related]
19. Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.
Grundy Q; Parker L; Wong A; Fusire T; Dimancesco D; Tisocki K; Walkowiak H; Vian T; Kohler J
Global Health; 2022 Mar; 18(1):33. PubMed ID: 35303902
[TBL] [Abstract][Full Text] [Related]
20. Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study.
Campsall P; Colizza K; Straus S; Stelfox HT
PLoS Med; 2016 May; 13(5):e1002029. PubMed ID: 27244653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
